NEW YORK (GenomeWeb News) – Gentronix today said that it has received a French research tax credit approval for the years 2012-2014.

The credit allows eligible research-intensive French companies who are subject to corporate tax in France the ability to claim tax relief on costs generated in R&D requirements that are outsourced to Gentronix. The firm is based in Manchester, UK, and provides genotoxicity screening products and services.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.

A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.

The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.

In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.